Higher Drug Prices, No Tariffs: U.K. Trade Pact Shows How Trump Is Coaxing Countries to Pay More for Meds

Higher Drug Prices, No Tariffs: U.K. Trade Pact Shows How Trump Is Coaxing Countries to Pay More for Meds

The Trump administration’s position on drug prices is that Americans pay too much while other countries don’t pay nearly enough. A new trade deal with the United Kingdom is addressing that imbalance, raising prices the national health system will pay for new medicines in exchange for tariff exemptions on U.K. pharmaceutical exports valued at about $3.5 billion a year.The deal announced Monday is an update to a broad trade deal the U.S. struck wi…

Pharmalittle: We're reading about FDA's Pazdur retiring, Europe's reaction to U.S.-U.K. pharma deal, and more

CVS Health will pay $37.76 million to settle charges it dispensed too many insulin pens to patients and got improper Medicare reimbursements